feed,title,long_url,short_url
Barron's,Sanofi Is Buying a U.S. Biotech Firm for $3.7 Billion,https://www.barrons.com/articles/sanofi-principia-stock-deal-biotech-multiple-sclerosis-drug-sar442168-ceo-paul-hudson-51597674189?mod=RTA,https://j.mp/3g5h1E2
